SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to a recently announced AI cloud partnership with Microsoft, valued at approximately $9.7 billion, sparking excitement around the company's potential in the AI infrastructure space. Community discussions revolve around the significance of the deal, access to Nvidia's GB300 GPUs, and comparing IREN to peers in the data center and AI sectors. Investors are also closely monitoring upcoming earnings and anticipating further developments in the AI cloud landscape.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining traction, particularly within the Solana ecosystem, with community members actively discussing its potential alongside symbols like $SOL and $PUMP. There's excitement around a recent article highlighting the project's community-driven approach, fostering a sense of shared optimism and collaboration among holders. Despite market volatility, the community maintains a bullish outlook, emphasizing long-term vision and resilience.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending as investors discuss potential catalysts following IREN's AI cloud contract, with anticipation building for CIFR's upcoming earnings and potential deals in the AI infrastructure space. Community members are weighing the potential impact of earnings on the stock's price, with some expressing concerns about hype and potential pullbacks. Bullish sentiment remains, driven by the company's positioning in the AI sector and expectations for significant growth.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending with community members actively discussing trading strategies and expressing a mix of bullish sentiment and frustration with recent price action. Mentions of staking rewards and potential for long-term growth are circulating, alongside discussion of meme tokens on the Solana network like $WAGMI, $BROKE, and $SLAP, indicating interest in the Solana ecosystem.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending with traders discussing its potential for a significant upward move due to its low float and recent bullish momentum. Community members are watching for breakout levels, anticipating a possible short squeeze and a run towards higher price targets. Bullish sentiment is building, with many noting the increasing number of watchers and the stock's ability to hold its ground in a volatile market.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

Enthusiastic community members are rallying behind SLAP, emphasizing its strong meme potential and real-world partnerships. Discussions highlight the team's dedication and the project's cultural relevance, reflected in the recurring phrase "that slaps." With a focus on community-driven growth, SLAP aims to make a mark in the meme coin space.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending amid concerns around potential legal challenges related to talc lawsuits and recent discussions about a possible link between Tylenol and autism, despite scientific consensus pushing back on the link. The stock is oversold and dip buyers are stepping in, with many in the community believing it is undervalued. Traders are actively discussing options strategies and potential price targets, while closely monitoring upcoming earnings.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to positive community sentiment surrounding recent earnings and future revenue expectations for BRIUMVI. Traders are closely watching revenue growth and EPS, with many expressing optimism about a potential breakout. Discussions also involve potential buyback programs, Neuraxpharm, and upcoming clinical data.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a lawsuit filed against a former FDA official, George Tidmarsh, accused of soliciting a bribe and making false statements that negatively impacted the stock; the community is discussing the implications for the company and potential stock manipulation; This comes as AUPH shareholders look forward to upcoming earnings.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending due to a regulatory update from the FDA regarding its Huntington's disease treatment, AMT-130, leading to community discussion about the future of the drug's approval. While some traders express concerns about the shift in FDA's position and the impact on the timeline for Biologics License Application (BLA) submission, others remain optimistic about the potential of the gene therapy and the company's pipeline, pointing to potential acquisition in the biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Altria's on! PLUS Launch Fuels Oral Tobacco Profit Gains: What's Next?

MO's Helix unit drives margin gains as new on! PLUS nicotine pouches launch in key states amid tough pricing pressure.

Is Altria Group (MO) Stock Outpacing Its Consumer Staples Peers This Year?

Here is how Altria (MO) and Ambev (ABEV) have performed compared to their sector so far this year.

After Plunging 13.1% in 4 Weeks, Here's Why the Trend Might Reverse for Altria (MO)

Altria (MO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Altria's Q3 Earnings Beat Estimates, Revenues Decline Y/Y

MO's third-quarter profit tops expectations on higher pricing and cost savings, even as cigarette and oral tobacco sales slip.

Here's What Key Metrics Tell Us About Altria (MO) Q3 Earnings

While the top- and bottom-line numbers for Altria (MO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Altria (MO) Tops Q3 Earnings Estimates

Altria (MO) delivered earnings and revenue surprises of +0.69% and -1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Altria Reports 2025 Third-Quarter and Nine-Months Results; Announces Expanded Share Repurchase Program; Narrows 2025 Full-Year Earnings Guidance

Altria Group, Inc. (NYSE: MO) today reports our 2025 third-quarter and nine-months business results, announces the expansion of our existing share repurchase program and narrows our guidance for 2025...

MO vs. PM: The Ultimate Face-Off in a Changing Tobacco Landscape

Altria's pricing power, smoke-free gains and solid margins make it a standout against Philip Morris in a transforming tobacco market.

Should You Consider Buying Altria Stock Before Q3 Earnings Release?

MO's Q3 results are likely to gain strength from pricing power, cost discipline and growing smoke-free momentum.


What Analyst Projections for Key Metrics Reveal About Altria (MO) Q3 Earnings

Evaluate the expected performance of Altria (MO) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$1.32	--	--	N/A
Q3 '25	$1.44	$1.45	0.70%	BEAT
Q2 '25	$1.39	$1.44	3.84%	BEAT
Q1 '25	$1.19	$1.23	3.60%	BEAT
Q4 '24	$1.28	$1.29	0.83%	BEAT

MO
Altria Group Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest MO News

MOAltria Group Inc.